Endometriosis Market Share, Industry Growth, Trend, Drivers, Challenges, Key Companies by 2028

Increasing awareness about women's health, increasing occurrence rate of the condition, the rising focus on clinical trials are some of the factors boosting the endometriosis market.
Market Size – USD 2,060.1 Million in 2020, Market Growth - CAGR of 2.6%, Market Trends –The increasing focus on clinical trial.
The Global endometriosis market is forecast to reach USD 2,544.2 Million by 2028, according to a new report by Reports and Data. Endometriosis is the resultant of the growth of endometrial tissue on bowel, ovaries, and tissues lining the pelvis. The hormonal changes associated with the menstrual cycle impacts the misplaced endometrial tissue that results in the area to become inflamed that causes pain. It implies that the tissue will thicken, grow, and break down. With time, the tissue that broken down has nowhere to go and becomes trapped in pelvis.
The market is projected to witness considerable growth during the forecast period. One of the mentionable factors in this regards being, the increasing occurrence rate of the condition. It has turned out to be a common gynecological condition, affecting approximately 10% of women. Treatment for the disease is dependent on the severity of the disease, symptoms, and if the care user wishes to have children. The condition is treatable with surgery, medication, or both. Medication is usually tried first when pain is the primary problem. Medications that are prescribed to treat the condition include pain relievers like nonsteroidal anti-inflammatory drugs (NSAIDs), and hormonal medications, including gonadotropin-releasing hormone agonists and birth control pills, progestin. Hormonal medications help minimize the growth of the endometrial tissue and may prevent the formation of new adhesions. Though it is mentionable that, these drugs are usually not effective in getting rid of endometriosis tissue that is already there. In regards to surgical options, Conservative surgery like Laparoscopy, hysterectomy are some of the available options.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2553

The report provides comprehensive assessment of the market covering key elements such as revenue estimations, cost analysis, import/export, production and consumption trends, CAGR, gross margin, and supply & demand patterns. It also sheds light on recent technological developments, product advancements, and research and development activities in the region.
The report examines the key players operating in the market along with their market position, market share, revenue, gross margin, and business strategies. SWOT analysis and Porter’s Five Forces Analysis are used to examine and assess the market and its players. It also covers recent mergers and acquisitions, joint ventures, collaborations, agreements, partnerships, and product launches and brand promotions.

Key companies profiled in the report include:
Johnson & Johnson Services Inc., Bayer AG, Neurocrine Biosciences Inc., Meditrina Pharmaceuticals Inc., AbbVie Inc., Astellas Pharma Inc., AstraZeneca Plc, Evotec AG, Debiopharm Group and Teva Pharmaceutical Industries Ltd.

Market Segmentation by Types:

Surgery Type Outlook (Revenue, USD Billion; 2020-2028)
• Laparoscopy
• Laparotomy
• Pelvic nerves surgery
Drug Type Outlook (Revenue, USD Billion; 2020-2028)
• NSAID’s
• Gonadotropins Releasing Hormone Agonists
• Progestin
• Oral Contraceptive Pills
End-Users Type Outlook (Revenue, USD Billion; 2020-2028)
• Hospital
• Pharmacies
• Drugstores
• E-commerce

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/2553

Regional analysis covers in-depth analysis of analysis of the revenue, market share, and growth rate of the global Endometriosis market in each region for the forecast period of 2021-2028. The report covers production and consumption rate, current and emerging trends, import/export, supply and demand, and presence of key players in each region.

• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o U.K.
o Italy
o France
o BENELUX
o Rest of Europe
• Asia Pacific
o China
o India
o Japan
o South Korea
o Rest of APAC
• Latin America
o Brazil
o Rest of LATAM
• Middle East & Africa
o Saudi Arabia
o U.A.E.
o South Africa
o Rest of MEA

To know more about the report @ https://www.reportsanddata.com/report-detail/endometriosis-market

Further key findings from the report suggest
• The endometriosis market held a market share of USD 2,060.1 Million in the year 2020 and forecasted to grow at a rate of 2.6% during the forecast period.
• In regards to Drug Type, the NSAID’s segment generated the highest revenue of USD 0.58 Billion in 2020, with a growth rate of 2.9% during the forecast period. The effectiveness of the medicine in relieving pain caused by the condition, which are nonsteroidal anti-inflammatory drugs that work by discontinuing the release of prostaglandins that is one of the main chemicals resulting in the pain, contributes to the revenue generated by the NSAID’s segment.
• In context to Surgery Type, the Laparoscopy segment yielded the highest revenue of USD 0.87 Billion in 2020, with the fastest growth rate of 3.2% during the forecast period. The effectiveness of this surgery in accurately diagnosing endometriosis and even eliminate it in mild-moderate condition with just a small incision resulted in its increased demand and revenue generated by the
• In regards to the End-users, the Drugstores segment can be seen to occupy the largest market share of 30.2% in 2020, with the second-highest growth rate of 3.1% during the forecast period. The fact that in most cases of endometriosis, pain in the primary issue, in which medication is the first choice, has resulted in high dependency on drugstores for availing the prescribed medication, which contributes to the market share occupied by this segment.
• In context to region, Asia Pacific is projected to witness the fastest growth rate of 5.5% during the forecast period, which occupied the second-largest market share of 24.3% in 2020. The growth rate experienced by the Asia Pacific region is resultant of continuous growth in healthcare technology and the rising awareness about women’s health.

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/2553

Thank you for reading our report. For further inquiry, please connect with us and our team will make sure the report is customized according to your requirements.

Browse More Reports:

Biomaterials Market @ https://www.google.ga/url?q=https://www.reportsanddata.com/report-detail/biomaterials-market

Surgical Microscopes Market @ https://www.google.fr/url?q=https://www.reportsanddata.com/report-detail/surgical-microscopes-market

Gemcitabine HCl Market @ https://www.google.hu/url?q=https://www.reportsanddata.com/report-detail/gemcitabine-hcl-market

Gynaecological Examination Chairs Market @ https://www.google.com.ua/url?q=https://www.reportsanddata.com/report-detail/gynaecological-examination-chairs-market

Laser Therapy Caps Market @ https://www.google.cl/url?q=https://www.reportsanddata.com/report-detail/laser-therapy-caps-market

Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com

About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

This release was published on openPR.